Literature DB >> 2504407

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.

B A Oppenheim1, J W Hartley, W Lee, J P Burnie.   

Abstract

OBJECTIVE: To define an outbreak of bacteraemia due to coagulase negative staphylococci highly resistant to ciprofloxacin in a leukaemia unit, investigate the source and mode of spread of the outbreak strain, and assess control measures.
DESIGN: The outbreak strain was characterised by five different typing methods. Surveillance of patients, staff, and environment was carried out during the outbreak and five months after control measures were introduced.
SETTING: A unit with 10 beds for adults with leukaemia and patients receiving bone marrow transplants. The outbreak occurred during a trial of ciprofloxacin for empirical treatment of neutropenic fevers.
INTERVENTIONS: Ciprofloxacin was withdrawn from use in the unit and daily bathing with chlorhexidine gluconate solution started. Main outcome measure--The absence of bacteraemia due to the outbreak strain for five months after control measures.
RESULTS: During the study 49 patients developed 21 episodes of bacteraemia due to the outbreak strain, which was ciprofloxacin resistant (minimum inhibitory concentration greater than or equal to 128 mg/l), susceptible to phage 155 A9C, and SII biotype and had characteristic immunoblot and DNA fingerprint features. There was a high amount of colonisation of patients but not staff with this strain, which was also wide spread in the environment. The control measures led to rapid resolution of the outbreak and disappearance of the strain from the unit.
CONCLUSIONS: In areas where coagulase negative staphylococcal infections are common doctors must be aware of the possibility of cross infection with single strain, and the availability of more discriminatory methods of typing will facilitate the identification and control of such episodes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504407      PMCID: PMC1837150          DOI: 10.1136/bmj.299.6694.294

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

2.  Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis.

Authors:  P J van den Broek; A S Lampe; G A Berbée; J Thompson; R P Mouton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

3.  Problems in the investigation of an apparent outbreak of coagulase-negative staphylococcal septicaemia following cardiac surgery.

Authors:  E T Houang; R R Marples; I Weir; A J Mourant; M J de Saxe; B Singleton
Journal:  J Hosp Infect       Date:  1986-11       Impact factor: 3.926

4.  Ciprofloxacin-resistant Staphylococcus aureus.

Authors:  H Humphreys; E Mulvihill
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

5.  Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.

Authors:  B A Oppenheim; J W Hartley; W Lee; J P Burnie
Journal:  BMJ       Date:  1989-07-29

6.  A comparison of DNA and immunoblot fingerprinting of the SII biotype of coagulase negative staphylococci.

Authors:  J P Burnie; W Lee
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

Review 7.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Hands as route of transmission for Klebsiella species.

Authors:  M Casewell; I Phillips
Journal:  Br Med J       Date:  1977-11-19

9.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more
  19 in total

1.  Comparative evaluation of a new molecular method for typing Staphylococcus epidermidis.

Authors:  J Wilton; K Jung; I Vedin; B Aronsson; J I Flock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period.

Authors:  O Lyytikäinen; M Vaara; E Järviluoma; K Rosenqvist; L Tiittanen; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

4.  DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections.

Authors:  B M Dobbins; P Kite; A Kindon; M J McMahon; M H Wilcox
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

5.  An epidemiological study of blood culture isolates of coagulase-negative staphylococci demonstrating hospital-acquired infection.

Authors:  J P Burnie; M Naderi-Nasab; K W Loudon; R C Matthews
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 6.  Antimicrobial susceptibility of coagulase-negative staphylococci.

Authors:  G L Archer; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors:  W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors.

Authors:  C L Vermont; N G Hartwig; A Fleer; P de Man; H Verbrugh; J van den Anker; R de Groot; A van Belkum
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.

Authors:  S M Kelsey; B Weinhardt; P W Collins; A C Newland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.